Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Imaging Modalities in the Evaluation of Patients With Ectopic Cushing's Syndrome
NCT00001849Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- May 1999
- Primary completion
- Apr 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fluorodopa F 18, fludeoxyglucose f 18, pentetreotide in Cushing syndrome, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started May 1999; status: completed.
02
Drugs
Fluorodopa F 18fludeoxyglucose f 18pentetreotide
03
Conditions
Cushing syndrome
Beyond the preview
Go deeper on NCT00001849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001849.